One new study shows women with HER2-positive early breast cancer were able to be successfully treated without chemotherapy thus avoiding its harsh side effects.
June 15, 2023 – Sometimes less may be more, and researchers are increasingly looking at ways that cancer therapy can be safely “de-escalated,” making a patient's care less aggressive without affecting their odds of survival. One new study shows women with HER2-positive early breast cancer were able to be successfully treatedHER2 positive breast cancer is not that common, and diagnosed in about 1 in 5 women with breast cancer.
In this study, Cortes and his team divided 356 patients over the age of 18, who had operable, early stage HER2+ breast cancer, into two groups, A and B. Both groups went on to surgery, following their initial therapy. After surgery, patients who did not show any signs of cancer continued their treatment without chemotherapy. The rest of the patients received chemotherapy.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
The global patent landscape of HER2-targeted biologics - Nature BiotechnologyGlobal patents on HER2-targeted biologics show rapid growth and a diversified technology pattern.
Baca lebih lajut »
Mercedes Vision One-Eleven Is A Futuristic EV Hypercar With One Eye On the Past | CarscoopsVision One-Eleven concept is inspired by Mercedes C111 prototypes of the '60s and ‘70s and features lightweight axial-flux electric motors car auto cars
Baca lebih lajut »
Extraction 2 and the two Hemsworths: One silly, one never sillyExtraction 2 could be proof that there are two Chris Hemsworths: A silly one and no silly ever one
Baca lebih lajut »
First or Second-Line CDK4/6 Inhibition in Breast Cancer?Patients with advanced ER+/HER2– breast cancer receiving first line CDK4/6 inhibitor therapy experienced no progression-free survival or overall survival advantages compared to second line therapy.
Baca lebih lajut »